Program
Day one – wednesday
08:00 Registration tea/coffee
09:00 Welcome remarks
Session 1 – Chair:
Derek Bowie – McGill University
09:15 TBA
TBA
09:40 Teresa Pérez García – University of Valladolid
Kv1.3 channels as new targets in cardiovascular disease
10:05 Susumu Ohya – Nagoya City University
Role of Ca2+-activated K+ and Cl- channels in cancer drug resistance
10:30 Tea/coffee, Exhibits and Posters
11:15 Shreya Parthadas Sharma – Edinburgh University
TBA
11:40 Bernard Attali – Tel Aviv University
Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K+ channels for atrial fibrillation treatment
12:05 Emma Veale – University of Kent
Characterisation of monogenic clinical variants of potassium channels to understand their contribution in disease phenotypes
12:30 Maurizio Taglialatela – University of Naples Federico II
Neuronal KCNQ channelopathies: human phenotypes, functional aspects and pharmacological approaches
12:55 Lunch – networking, exhibits and posters
Session 2 – Chair:
Teresa Pérez García – University of Valladolid
14:00 Jeremy Lambert – University of Dundee
Neurosteroids – Endogenous modulators of the GABAA receptor
14:25 Flore Sneyers – Catholic University Leuven
An unanticipated Ca2+-independent effect of BAPTA uncovers a new way to target Mcl-1-dependent cancer cells
14:50 Nasreen Choudhury – Evotec AOI
Nav channels: drugging the dark side with high throughput
15:15 Tea/coffee, Exhibits and Posters
16:00 Iain Greenwood – St George’s, University of London
ERG channels: not just an affair of the heart
16:25 Haritha Reddy – Tel Aviv University
Molecular mechanisms underlying the epileptic symptoms of GNB1
16:50 Thomas Binzer – Sophion Bioscience
Sophion news & views
17:15 Wrap up
17:30 Drinks reception at the Scholar’s Garden
19:00 Dinner at the Great Hall, Clare College
Day two- Thursday
08:00 Tea/coffee
09:00 Welcome remarks
Session 3 – Chair:
Barbara Ehrlich – Yale University
09:05 Guiscard Seebohm – University of Münster
Kv7 channels – You can teach even old dogs new tricks
09:30 Arden Darko-Boateng – Columbia University
Cav3.1 and Cav3.2 Low voltage-activated Calcium Channels by NEDD4 Family E3 Ubiquitin Ligases
09:55 Kim Boddum – Sophion Bioscience A/S
Neurological disease models using Automated Patch Clamp platforms (Qube 384 & QPatch)
10:20 Tea/coffee, Exhibits and Posters
11:20 Thomas Voets – Catholic University Leuven
TRPM3 – from the periphery to the brain
11:45 Serife Yerlikaya – University of York
Effects of chemotherapy drugs on voltage-gated sodium channels in breast cancer cells
12:00 Hiroshi Kuba – Nagoya University
Activity-dependent distribution of sodium channels at the axon initial segment of neurons
12:25 Michael Pusch – Genova Institute of Biophysics
Molecular determinants of oxidation dependence of volume-regulated anion channels
12:50 Lunch – networking, exhibits and posters
Session 4 – Chair:
Iain Greenwood – St George’s, University of London
14:00 Derek Bowie – McGill University
The glutamatergic synapse as a hub for neurodevelopmental disorders
14:25 Roope Mannikko – University College London
Nav1.4 channelopathies- novel phenotypes and mechanisms
14:50 Barbara Erhlich – Yale University
From basic science to clinical trials: lessons from chemotherapy
15:15 Makiko Kashio – National Insitute for Physiological Sciences, Japan
TRPM2 as a body temperature sensor
15:40 Wrap-up